Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Med (New York, N.Y.)|June 12, 2026
Diabetic retinal disease: Five trials to watchHannah Khan, Aamir A Aziz, Arshad M Khanani, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 20, 2023
Cooling Anesthesia for Intravitreal Injections - A ReviewPriya R Chandrasekaran, Aamir A Aziz, Hannah Khan, et al.
Expert Opinion on Drug Delivery|April 6, 2026
An update on the port delivery system with ranibizumab for retinal diseasesMaya Samman, Hannah Khan, Aamir A Aziz, et al.
Cells|August 14, 2020
Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving FaricimabMajid Khan, Aamir A Aziz, Noah A Shafi, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 29, 2021
Emerging Therapies in Nonexudative Age-Related Macular Degeneration in 2020Anindya Samanta, Aamir A Aziz, Mahima Jhingan, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 9, 2020
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020Anindya Samanta, Aamir A Aziz, Mahima Jhingan, et al.
Expert Opinion on Drug Safety|August 5, 2024
Approved treatments for neovascular age-related macular degeneration: current safety and future directionsHannah Khan, Aamir A Aziz, Zoha Khanani, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 6, 2023
Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular DegenerationHannah Khan, Aamir A Aziz, Humza Sulahria, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 13, 2021
Angiopoietins as Potential Targets in Management of Retinal DiseaseArshad M Khanani, Matthew W Russell, Aamir A Aziz, et al.
Expert Opinion on Drug Delivery|August 14, 2021
Port delivery system: a novel drug delivery platform to treat retinal diseasesArshad M Khanani, Aamir A Aziz, Christina Y Weng, et al.
Pageof 2